These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 31201643)

  • 1. Decision Models for Assessing the Cost Effectiveness of Treatments for Pediatric Drug-Resistant Epilepsy: A Systematic Review of Economic Evaluations.
    Elliott J; van Katwyk S; McCoy B; Clifford T; Potter BK; Skidmore B; Wells GA; Coyle D
    Pharmacoeconomics; 2019 Oct; 37(10):1261-1276. PubMed ID: 31201643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of cannabinoids for pediatric drug-resistant epilepsy: protocol for a systematic review of economic evaluations.
    Elliott J; McCoy B; Clifford T; Potter BK; Skidmore B; Wells GA; Coyle D
    Syst Rev; 2019 Mar; 8(1):75. PubMed ID: 30917869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of economic evaluations of treatments for patients with epilepsy.
    Wijnen BFM; van Mastrigt GAPG; Evers SMAA; Gershuni O; Lambrechts DAJE; Majoie MHJM; Postulart D; Aldenkamp BAP; de Kinderen RJA
    Epilepsia; 2017 May; 58(5):706-726. PubMed ID: 28098939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluations of nonpharmacological treatments for drug-resistant epilepsy: A systematic review.
    Chan HY; Janssen LMM; Wijnen BFM; Hiligsmann M; Majoie MHJM; Evers SMAA
    Epilepsia; 2023 Nov; 64(11):2861-2877. PubMed ID: 37545415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of epileptic surgery compared with medical treatment in children with drug-resistant epilepsy.
    Catchpool M; Dalziel K; Mahardya RTK; Harvey AS
    Epilepsy Behav; 2019 Aug; 97():253-259. PubMed ID: 31254845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Review of Cost-Effectiveness Analysis for Surgical and Neurostimulation Treatments for Drug-Resistant Epilepsy in Adults.
    Ngan Kee N; Foster E; Marquina C; Tan A; Pang SST; O'Brien TJ; Kwan P; Jackson GD; Chen Z; Ademi Z
    Neurology; 2023 May; 100(18):e1866-e1877. PubMed ID: 36927880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Review of Economic Evaluations of Systemic Treatments for Advanced and Metastatic Gastric Cancer.
    Sharma S; Carey N; McConnell D; Lowery M; O'Sullivan J; McCullagh L;
    Pharmacoeconomics; 2024 Oct; 42(10):1091-1110. PubMed ID: 39060831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers in accessing medical cannabis for children with drug-resistant epilepsy in Canada: A qualitative study.
    Elliott J; DeJean D; Potter BK; Coyle D; Clifford T; McCoy B; Wells GA
    Epilepsy Behav; 2020 Oct; 111():107120. PubMed ID: 32570201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
    Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
    Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical effectiveness and cost-effectiveness of newer drugs for children with epilepsy. A systematic review.
    Connock M; Frew E; Evans BW; Bryan S; Cummins C; Fry-Smith A; Li Wan Po A; Sandercock J
    Health Technol Assess; 2006 Mar; 10(7):iii, ix-118. PubMed ID: 16545206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-utility analysis of competing treatment strategies for drug-resistant epilepsy in children with Tuberous Sclerosis Complex.
    Fallah A; Weil AG; Wang S; Lewis E; Baca CB; Mathern GW
    Epilepsy Behav; 2016 Oct; 63():79-88. PubMed ID: 27591681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness of Medicinal Cannabis for Management of Refractory Symptoms Associated With Chronic Conditions: A Systematic Review of Economic Evaluations.
    Erku D; Shrestha S; Scuffham P
    Value Health; 2021 Oct; 24(10):1520-1530. PubMed ID: 34593176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
    Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R
    Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of surgical treatment compared to medical treatment in patients with drug-refractory epilepsy: A systematic review.
    Kitschen A; Aleknonytė-Resch M; Sakalytė G; Diederich F
    Eur J Neurol; 2023 Mar; 30(3):749-761. PubMed ID: 36371643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model-Based Economic Evaluations of Interventions for Dementia: An Updated Systematic Review and Quality Assessment.
    Darab MG; Engel L; Henzler D; Lauerer M; Nagel E; Brown V; Mihalopoulos C
    Appl Health Econ Health Policy; 2024 Jul; 22(4):503-525. PubMed ID: 38554246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating Cost-Effectiveness Models for Pharmacologic Interventions in Adults with Heart Failure: A Systematic Literature Review.
    Di Tanna GL; Bychenkova A; O'Neill F; Wirtz HS; Miller P; Ó Hartaigh B; Globe G
    Pharmacoeconomics; 2019 Mar; 37(3):359-389. PubMed ID: 30596210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of the quality and scope of decision modelling studies in child oral health research.
    Taylor GD; Carr K; Rogers HJ; Vernazza CR
    BMC Oral Health; 2021 Jun; 21(1):318. PubMed ID: 34167525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of oral cannabis extracts in children with epilepsy.
    Knupp KG; Rice JD; Helmkamp LJ; Galinkin J; Sempio C; Jost K; Chapman KE
    Seizure; 2019 Nov; 72():23-27. PubMed ID: 31550641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.